Shilpa Medicare gains on entering into strategic partnership with NXI Therapeutics AG

Shilpa Medicare gains on entering into strategic partnership with NXI Therapeutics AG

Mumbai, February 13 (Udaipur Kiran): Shilpa Medicare is currently trading at Rs. 329.00, up by 5.70 points or 1.76% from its previous closing of Rs. 323.30 on the BSE. The scrip opened at Rs. 321.00 and has touched a high and low of Rs. 332.00 and Rs. 315.60 respectively. So far 6330 shares were traded … Read more

Shilpa Medicare Gains on EMA Nod for Rivaroxaban Orodispersible Films

Shilpa Medicare

(Udaipur Kiran News): Shares of Shilpa Medicare climbed over 2% in Tuesday’s trade after the company received initial authorization from the European Medicines Agency (EMA) for its Rivaroxaban Orodispersible Films. The stock was trading at ₹839.65, up 2.74%, compared to its previous close of ₹817.25 on the BSE. It opened at ₹823.00 and touched an … Read more

Shilpa Medicare introduces Capecitabine 1000 MG dispersible tablet

Shilpa Medicare

Shilpa Medicare has introduced Capecitabine 1000 MG dispersible tablet for the first time in the world, with novel technology of faster dispersion within 90 seconds. The company has launched the product in the Indian market on December 16, 2022 and is further looking to introduce Capebel 1 gm DT in various international markets through its … Read more

Shilpa Medicare gets nod from European Authorities for Pemetrexed Injection

Shilpa Medicare

Shilpa Medicare’s Pemetrexed Injection 1000 mg/100 ml, 500 mg/50 ml & 100 mg/10 ml, Ready to use formulation is approved by European Authorities, through its agreed partners in Europe. The product will be manufactured, for EU commercialization at its own EU GMP compliant, injectable manufacturing facility situated in Telangana state. Shilpa has developed Pemetrexed formulation … Read more

Shilpa Medicare zooms as its finished dosage formulation facility gets GMP certification from Russian Federation

Shilpa Medicare

Shilpa Medicare is currently trading at Rs. 531.00, up by 14.75 points or 4.21% from its previous closing of Rs. 516.25 on the BSE. The scrip opened at Rs. 519.00 and has touched a high and low of Rs. 543.10 and Rs. 510.00 respectively. So far 54211 shares were traded on the counter. The BSE … Read more

BREAKING NEWS:
Get 365-day plans under ₹2000 before price hike! IPL 2026: Vaibhav Sooryavanshi Leads in Sixes! Rajasthan Royals lose despite Sooryavanshi’s fiery innings: Key culprits!